nodgoРоссийский журнал детской гематологии и онкологии (РЖДГиО)Russian Journal of Pediatric Hematology and Oncology2311-12672413-5496LTD “Graphica”10.17650/2311-1267-2017-4-3-94-96nodgo-323Research ArticleДИСКУССИОННЫЙ КЛУБDISCUSSION CLUBРецензия на статью М. Штенгера «Риск развития вторых опухолей у детей, излеченных от злокачественных новообразований, снижается, но по-прежнему остается высоким»Review of the article by M. Stenger “Decreasing but still elevated risk for subsequent neoplasms in survivors of childhood cancers”ФатеевК. М.FateevK. M.

Россия, 117997, Москва, ул. Саморы Машела;  Россия, 115409, Москва, Каширское шоссе, 31

1 Samory Mashela St., Moscow, 117997, Russia; 31 Kashirskoe shosse, Moscow, 115409, Russia

 

 

k.m.fateev@gmail.comНечеснюкА. В.NechesnyukA. V.

Россия, 117997, Москва, ул. Саморы Машела

1 Samory Mashela St., Moscow, 117997, Russia

ФГБУ «НМИЦ ДГОИ им. Дмитрия Рогачева» Минздрава России; ФГАОУ ВО «Национальный исследовательский ядерный университет «МИФИ»РоссияDmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Health of Russia; National Research Nuclear University MEPhI (Moscow Engineering Physics Institute)Russian FederationФГБУ «НМИЦ ДГОИ им. Дмитрия Рогачева» Минздрава РоссииРоссияDmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Health of RussiaRussian Federation201725092017439496Copyright © Фатеев К.М., Нечеснюк А.В., 20172017Фатеев К.М., Нечеснюк А.В.Fateev K.M., Nechesnyuk A.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.nodgo.org/jour/article/view/323

.

.

ReferencesCancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975–1995, National Cancer Institute, SEER Program. Ries L.A.G., Smith M.A., Gurney J.G., Linet M., Tamra T., Young J.L., Bunin G.R. (eds.). NIH Pub. No. 99-4649. Bethesda, MD, 1999.Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975–1995, National Cancer Institute, SEER Program. Ries L.A.G., Smith M.A., Gurney J.G., Linet M., Tamra T., Young J.L., Bunin G.R. (eds.). NIH Pub. No. 99-4649. Bethesda, MD, 1999.Mertens A.C., Liu Q., Neglia J.P. et al. Cause-specific late mortality among 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. J Natl Cancer Inst 2008;100(19):1368–79. doi: 10.1093/jnci/ djn310.Mertens A.C., Liu Q., Neglia J.P. et al. Cause-specific late mortality among 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. J Natl Cancer Inst 2008;100(19):1368–79. doi: 10.1093/jnci/ djn310.Turcotte L.M., Liu Q., Yasui Y. et al. Temporal Trends in Treatment and Subsequent Neoplasm Risk Among 5-Year Survivors of Childhood Cancer, 1970–2015. JAMA 2017;317(8):814–24. doi: 10.1001/ jama.2017.0693.Turcotte L.M., Liu Q., Yasui Y. et al. Temporal Trends in Treatment and Subsequent Neoplasm Risk Among 5-Year Survivors of Childhood Cancer, 1970–2015. JAMA 2017;317(8):814–24. doi: 10.1001/ jama.2017.0693.De Bruin M.L., Sparidans J., van’t Veer M.B. et al. Breast cancer risk in female survivors of Hodgkin’s lymphoma: lower risk after smaller radiation volumes. J Clin Oncol 2009;27(26):4239–46. doi: 10.1200/ JCO.2008.19.9174.De Bruin M.L., Sparidans J., van’t Veer M.B. et al. Breast cancer risk in female survivors of Hodgkin’s lymphoma: lower risk after smaller radiation volumes. J Clin Oncol 2009;27(26):4239–46. doi: 10.1200/ JCO.2008.19.9174.Olch A.J. Pediatric Radiotherapy. Planning and Treatment. CRC Press, 2013. P. 24.Olch A.J. Pediatric Radiotherapy. Planning and Treatment. CRC Press, 2013. P. 24.Huq M.S., Das I.J., Steinberg T., Galvin J.M. A dosimetric comparison of various multileaf collimators. Phys Med Biol 2002;47(12):N159–70.PMID: 12118609.Huq M.S., Das I.J., Steinberg T., Galvin J.M. A dosimetric comparison of various multileaf collimators. Phys Med Biol 2002;47(12):N159–70.PMID: 12118609.Cui J., Liu C., Meng L., Benedict S. SU-E-T-128: A Comprehensive Dosimetric Characterization of the New 160 Leaf Elekta Agility Collimator System. Medical Physics 2013;40(6):233. doi: 10.1118/1.4814563.Cui J., Liu C., Meng L., Benedict S. SU-E-T-128: A Comprehensive Dosimetric Characterization of the New 160 Leaf Elekta Agility Collimator System. Medical Physics 2013;40(6):233. doi: 10.1118/1.4814563.Karlsson P., Holmberg E., Lundell M. et al. Intracranial tumors after exposure to ionizing radiation during infancy: a pooled analysis of two Swedish cohorts of 28,008 infants with skin hemangioma. Radiat Res 1998;150(3):357–64. PMID: 9728664.Karlsson P., Holmberg E., Lundell M. et al. Intracranial tumors after exposure to ionizing radiation during infancy: a pooled analysis of two Swedish cohorts of 28,008 infants with skin hemangioma. Radiat Res 1998;150(3):357–64. PMID: 9728664.Nguyen F., Rubino C., Guerin S. et al. Risk of a second malignant neoplasm after cancer in childhood treated with radiotherapy: correlation with the integral dose restricted to the irradiated fields. Int J Radiat Oncol Biol Phys 2008;70(3):908–15. doi: 10.1016/j. ijrobp.2007.10.034.Nguyen F., Rubino C., Guerin S. et al. Risk of a second malignant neoplasm after cancer in childhood treated with radiotherapy: correlation with the integral dose restricted to the irradiated fields. Int J Radiat Oncol Biol Phys 2008;70(3):908–15. doi: 10.1016/j. ijrobp.2007.10.034.Tukenova M., Guibout C., Hawkins M. et al. Radiation therapy and late mortality from second sarcoma, carcinoma, and hematological malignancies after a solid cancer in childhood. Int J Radiat Oncol Biol Phys 2011;80(2):339–46. doi: 10.1016/j. ijrobp.2010.02.004.Tukenova M., Guibout C., Hawkins M. et al. Radiation therapy and late mortality from second sarcoma, carcinoma, and hematological malignancies after a solid cancer in childhood. Int J Radiat Oncol Biol Phys 2011;80(2):339–46. doi: 10.1016/j. ijrobp.2010.02.004.D’Souza W.D., Rosen I.I. Nontumor integral dose variation in conventional radiotherapy treatment planning. Med Phys 2003;30(8):2065–71. doi: 10.1118/1.1591991.D’Souza W.D., Rosen I.I. Nontumor integral dose variation in conventional radiotherapy treatment planning. Med Phys 2003;30(8):2065–71. doi: 10.1118/1.1591991.Hermanto U., Frija E.K., Lii M.J. et al. Intensity-modulated radiotherapy (IMRT) and conventional three-dimensional conformal radiotherapy for high-grade gliomas: does IMRT increase the integral dose to normal brain? Int J Radiat Oncol Biol Phys 2007;67(4):1135–44. doi: 10.1016/j. ijrobp.2006.10.032.Hermanto U., Frija E.K., Lii M.J. et al. Intensity-modulated radiotherapy (IMRT) and conventional three-dimensional conformal radiotherapy for high-grade gliomas: does IMRT increase the integral dose to normal brain? Int J Radiat Oncol Biol Phys 2007;67(4):1135–44. doi: 10.1016/j. ijrobp.2006.10.032.Aoyama H., Westerly D.C., Mackie T.R. et al. Integral radiation dose to normal structures with conformal external beam radiation. Int J Radiat Oncol Biol Phys 2006;64(3):962–7. doi: 10.1016/j. ijrobp.2005.11.005.Aoyama H., Westerly D.C., Mackie T.R. et al. Integral radiation dose to normal structures with conformal external beam radiation. Int J Radiat Oncol Biol Phys 2006;64(3):962–7. doi: 10.1016/j. ijrobp.2005.11.005.Chung C.S., Yock T.I., Nelson K. et al. Incidence of second malignancies among patients treated with proton versus photon radiation. Int J Radiat Oncol Biol Phys 2013;87(1):46–52. doi: 10.1016/j. ijrobp.2013.04.030.Chung C.S., Yock T.I., Nelson K. et al. Incidence of second malignancies among patients treated with proton versus photon radiation. Int J Radiat Oncol Biol Phys 2013;87(1):46–52. doi: 10.1016/j. ijrobp.2013.04.030.

The authors declare that there are no conflicts of interest present.